Value of Information: A Tool to Improve Research Prioritization and Reduce Waste
In a Guest Editorial, Cosetta Minelli and Gianluca Baio explain how VOI analysis can prioritize research projects by identifying uncertainty in existing knowledge and then estimating expected benefits from reducing that uncertainty.
Vyšlo v časopise:
Value of Information: A Tool to Improve Research Prioritization and Reduce Waste. PLoS Med 12(9): e32767. doi:10.1371/journal.pmed.1001882
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001882
Souhrn
In a Guest Editorial, Cosetta Minelli and Gianluca Baio explain how VOI analysis can prioritize research projects by identifying uncertainty in existing knowledge and then estimating expected benefits from reducing that uncertainty.
Zdroje
1. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gulmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65. doi: 10.1016/S0140-6736(13)62229-1 24411644
2. Fleurence RL, Torgerson DJ. Setting priorities for research. Health policy. 2004;69(1):1–10. 15484602
3. Michaud CM, Murray CJ, Bloom BR. Burden of disease—implications for future research. Jama. 2001;285(5):535–9. 11176854
4. Phelps CE, Parente ST. Priority setting in medical technology and medical practice assessment. Medical care. 1990;28(8):703–23. 2117223
5. Buxton M, Hanney S. How can payback from health services research be assessed? Journal of health services research & policy. 1996;1(1):35–43. 10180843
6. Davies L, Drummond M, Papanikolaou P. Prioritizing investments in health technology assessment. Can we assess potential value for money? International journal of technology assessment in health care. 2000;16(1):73–91. 10815355
7. Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research: some lessons from recent UK experience. PharmacoEconomics. 2006;24(11):1055–68. 17067191
8. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health economics. 1996;5(6):513–24. 9003938
9. Howard RA. Information Value Theory. IEEE Transactions on Systems Science and Cybernetics; 1966.
10. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. West Sussex: Wiley; 2004.
11. Guide to the methods of technology appraisal. NICE; 2013. https://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf.
12. Mohseninejad L, van Baal PH, van den Berg M, Buskens E, Feenstra T. Value of information analysis from a societal perspective: a case study in prevention of major depression. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2013;16(4):490–7. doi: 10.1016/j.jval.2012.12.007 23796282
13. Holmes D. Report triggers quibbles over QALYs, a staple of health metrics. Nature medicine. 2013;19(3):248. doi: 10.1038/nm0313-248 23467219
14. Bojke L, Claxton K, Sculpher MJ, Palmer S. Identifying research priorities: the value of information associated with repeat screening for age-related macular degeneration. Medical decision making: an international journal of the Society for Medical Decision Making. 2008;28(1):33–43. doi: 10.1177/0272989X07309638. 18263560
15. Dong H, Coyle D, Buxton M. Value of information analysis for a new technology: computer-assisted total knee replacement. International journal of technology assessment in health care. 2007;23(3):337–42. 17579936
16. Micieli A, Bennell MC, Pham B, Krahn M, Singh SM, Wijeysundera HC. Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation. Journal of the American Heart Association. 2014;3(5):e001031. doi: 10.1161/JAHA.114.001031 25227405
17. Tuffaha HW, Gordon LG, Scuffham PA. Value of information analysis in oncology: the value of evidence and evidence of value. Journal of oncology practice / American Society of Clinical Oncology. 2014;10(2):e55–62. doi: 10.1200/JOP.2013.001108 24194511
18. Woods B, Veenstra D, Hawkins N. Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2011;14(8):989–1001. doi: 10.1016/j.jval.2011.05.048 22152167
19. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2015. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Apr2.pdf.
20. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–43. doi: 10.1016/S0140-6736(09)61303-9 19716966
21. Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, et al. Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Medical decision making: an international journal of the Society for Medical Decision Making. 2013;33(4):463–71. doi: 10.1177/0272989X13484388 23635833
22. Wald HL, Leykum LK, Mattison ML, Vasilevskis EE, Meltzer DO. Road map to a patient-centered research agenda at the intersection of hospital medicine and geriatric medicine. Journal of general internal medicine. 2014;29(6):926–31. doi: 10.1007/s11606-014-2777-1 24557516
23. Heath A MI, Baio G. A Review of Methods for the Analysis of the Expected Value of Information. Pre-publication manuscript arXiv:150702513 [statAP]; 2015. http://arxiv.org/pdf/1507.02513v1.pdf.
24. Strong M, Oakley JE, Brennan A. Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach. Medical decision making: an international journal of the Society for Medical Decision Making. 2014;34(3):311–26. doi: 10.1177/0272989X13505910 24246566
25. Welton NJ, Thom HH. Value of Information: We've Got Speed, What More Do We Need? Medical decision making: an international journal of the Society for Medical Decision Making. 2015;35(5):564–6. doi: 10.1177/0272989X15579164 25840903
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2015 Číslo 9
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer
- Simplified HIV Testing and Treatment in China: Analysis of Mortality Rates Before and After a Structural Intervention
- Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial
- Changes in Intake of Fruits and Vegetables and Weight Change in United States Men and Women Followed for Up to 24 Years: Analysis from Three Prospective Cohort Studies